Skip to contentApplication 211882
- Type
- NDA
- Sponsor
- BAUSCH
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ARAZLO | TAZAROTENE | LOTION;TOPICAL | 0.045% | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0187-2098 | Arazlo | tazarotene | Bausch Health US, LLC | NDA | Current |
| 0187-2098 | Arazlo | tazarotene | Bausch Health US LLC | NDA | Current |
| 0187-2098 | Arazlo | tazarotene | Bausch Health US, LLC | NDA | Current |
| 0187-2098 | Arazlo | tazarotene | Bausch Health US LLC | NDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 63844 | ORIG | 2020-07-10 |
| 61365 | ORIG | 2019-12-20 |
| 61350 | ORIG | 2019-12-19 |
| 63246 | ORIG | 1900-01-01 |